Abstract |
The effects of 5 and 10 mg bisoprolol once daily for 7 days on exercise ECG, myocardial perfusion and left ventricular function in 25 patients with stable coronary heart disease have been assessed in a double-blind, randomized, parallel group trial design. ST-segment depression during exercise was reduced by 56% by 5 mg bisoprolol and by 64% after 10 mg; the difference between the dose levels was significant. Heart rate, systolic and diastolic blood pressure and the rate-pressure product were reduced to similar extent both at rest and during exercise by both doses. Left ventricular thallium-201 scintigrams indicated a significant reduction in myocardial perfusion defects after 10 mg bisoprolol compared to baseline; however, the difference between the two active treatments was not significant. Left atrial and left ventricular diameters obtained by one-dimensional echocardiography, and the calculated shortening fraction, remained unchanged after bisoprolol, and so gave no evidence of a negative inotropic action. It is concluded that 5 mg bisoprolol was effective in once-a-day treatment of angina pectoris due to coronary heart disease, and a further improvement can be expected on increasing the dose to 10 mg.
|
Authors | B Maisch, U Borst, W Gerhards, G Wagner |
Journal | European journal of clinical pharmacology
(Eur J Clin Pharmacol)
Vol. 36
Issue 3
Pg. 217-22
( 1989)
ISSN: 0031-6970 [Print] Germany |
PMID | 2568261
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Adrenergic beta-Antagonists
- Propanolamines
- Bisoprolol
|
Topics |
- Adrenergic beta-Antagonists
(adverse effects, therapeutic use)
- Adult
- Aged
- Angina Pectoris
(drug therapy)
- Bisoprolol
- Blood Pressure
(drug effects)
- Coronary Circulation
- Coronary Disease
(drug therapy, physiopathology)
- Double-Blind Method
- Echocardiography
- Electrocardiography
- Female
- Heart
(physiopathology)
- Heart Rate
(drug effects)
- Humans
- Male
- Middle Aged
- Physical Exertion
- Propanolamines
(adverse effects, therapeutic use)
- Random Allocation
|